Get the Stockscreener App
3.17
7.58%
-0.26
After Hours:
3.17
Calcimedica Inc stock is traded at $3.17, with a volume of 68,519.
It is down -7.58% in the last 24 hours and up +27.82% over the past month.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
See More
Previous Close:
$3.43
Open:
$3.44
24h Volume:
68,519
Relative Volume:
0.95
Market Cap:
$44.29M
Revenue:
-
Net Income/Loss:
$-20.87M
P/E Ratio:
-1.9813
EPS:
-1.6
Net Cash Flow:
$-21.21M
1W Performance:
+2.92%
1M Performance:
+27.82%
6M Performance:
+65.10%
1Y Performance:
-23.80%
1-Day Range:
$3.01
$3.44
1-Week Range:
$3.0001
$3.73
52-Week Range:
$1.42
$5.65
Calcimedica Inc Stock (CALC) Company Profile
Name
Calcimedica Inc
Sector
Industry
Phone
858-952-5500
Address
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
3.17 | 48.76M | 0 | -20.87M | -21.21M | -1.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Calcimedica Inc Stock (CALC) Latest News
Has CalciMedica Inc. found a price floor2025 Earnings Surprises & High Return Stock Watch Alerts - Newser
Key metrics from CalciMedica Inc.’s quarterly dataJuly 2025 Short Interest & Weekly Top Gainers Alerts - Newser
Does CalciMedica Inc. fit your quant trading modelMarket Weekly Review & Weekly Chart Analysis and Trade Guides - Newser
Full technical analysis of CalciMedica Inc. stock2025 Winners & Losers & Precise Trade Entry Recommendations - Newser
Analyzing CalciMedica Inc. with multi timeframe chartsMarket Risk Report & AI Powered Market Trend Analysis - Newser
Real time alert setup for CalciMedica Inc. performanceMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Using Bollinger Bands to evaluate CalciMedica Inc.2025 Historical Comparison & Stepwise Swing Trade Plans - Newser
Will CalciMedica Inc. see short term momentumJuly 2025 Analyst Calls & Proven Capital Preservation Methods - Newser
Applying chart zones and confluence areas to CalciMedica Inc.Weekly Market Summary & Real-Time Price Movement Reports - Newser
How sentiment analysis helps forecast CalciMedica Inc.Treasury Yields & Weekly Market Pulse Updates - Newser
Can CalciMedica Inc. hit a new high this monthJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - Newser
analyzing calcimedica inc. with multi timeframe chartsDollar Strength & Community Driven Trade Alerts - Newser
Roberts, CalciMedica chief business officer, buys $7377 in stock By Investing.com - Investing.com Australia
Combining machine learning predictions for CalciMedica Inc.2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
Roberts, CalciMedica chief business officer, buys $7.3k in CALC - Investing.com
Roberts, CalciMedica chief business officer, buys $7377 in stock - Investing.com
Smart tools for monitoring CalciMedica Inc.’s price actionWeekly Loss Report & Reliable Price Breakout Alerts - Newser
Using economic indicators to assess CalciMedica Inc. potentialJuly 2025 Institutional & Smart Investment Allocation Tips - Newser
CalciMedica Inc. stock outlook for YEAR2025 AllTime Highs & Accurate Entry/Exit Alerts - Newser
Is CalciMedica Inc. stock ready for a breakout2025 Major Catalysts & Free Growth Oriented Trading Recommendations - Newser
Will CalciMedica Inc. stock recover after earningsDollar Strength & High Accuracy Trade Signal Alerts - beatles.ru
Tools to assess CalciMedica Inc.’s risk profileJuly 2025 Final Week & Verified Technical Signals - Newser
Calcimedica Inc Stock (CALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):